Gene · 429
Papers4,495
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 4,495
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A conserved molecular logic for neurogenesis to gliogenesis switch in the cerebral cortex. | Proc Natl Acad Sci U S A | 2024 | 38713624 | PubTator, text mining | PubMed |
| Prognostic Implications of Small Cell Lung Cancer Transcriptional Subtyping for CNS Metastases. | JCO Precis Oncol | 2024 | 38691815 | PubTator, text mining | PubMed |
| Methylation markers for anal cancer screening: A repeated cross-sectional analysis of people living with HIV, 2015-2016. | Int J Cancer | 2024 | 38680109 | PubTator, text mining | PubMed |
| Lineage Reprogramming: Genetic, Chemical, and Physical Cues for Cell Fate Conversion with a Focus on Neuronal Direct Reprogramming and Pluripotency Reprogramming. | Cells | 2024 | 38667322 | PubTator, text mining | PubMed |
| Sex-specific expression of distinct serotonin receptors mediates stress vulnerability of adult hippocampal neural stem cells in mice. | Cell Rep | 2024 | 38656873 | PubTator, text mining | PubMed |
| Quiescent Adult Neural Stem Cells: Developmental Origin and Regulatory Mechanisms. | Neurosci Bull | 2024 | 38656419 | PubTator, text mining | PubMed |
| Human olfactory neural progenitor cells reveal differences in IL-6, IL-8, thrombospondin-1, and MCP-1 in major depression disorder and borderline personality disorder. | Front Psychiatry | 2024 | 38654728 | PubTator, text mining | PubMed |
| ASCL1-mediated direct reprogramming: converting ventral midbrain astrocytes into dopaminergic neurons for Parkinson's disease therapy. | BMB Rep | 2024 | 38649147 | PubTator, text mining | PubMed |
| PGC-1α drives small cell neuroendocrine cancer progression towards an ASCL1-expressing subtype with increased mitochondrial capacity. | bioRxiv | 2024 | 38645232 | PubTator, text mining | PubMed |
| Spatially Preserved Multi-Region Transcriptomic Subtyping and Biomarkers of Chemoimmunotherapy Outcome in Extensive-Stage Small Cell Lung Cancer. | Clin Cancer Res | 2024 | 38630755 | PubTator, text mining | PubMed |
| Directed Differentiation of Neurons from Human iPSCs for Modeling Neurological Disorders. | Methods Mol Biol | 2024 | 38630226 | PubTator, text mining | PubMed |
| A Path to Persistence after EGFR Inhibition. | Cancer Res | 2024 | 38616658 | PubTator, text mining | PubMed |
| Molecular pathology of small cell lung cancer: Overview from studies on neuroendocrine differentiation regulated by ASCL1 and Notch signaling. | Pathol Int | 2024 | 38607250 | PubTator, text mining | PubMed |
| POU2F3-expressing intraepithelial small-cell carcinoma with mixed small-cell carcinoma and conventional-type urothelial carcinoma of the urinary bladder. | Virchows Arch | 2024 | 38600174 | PubTator, text mining | PubMed |
| Molecular phenotyping of small cell lung cancer using targeted cfDNA profiling of transcriptional regulatory regions. | Sci Adv | 2024 | 38598634 | PubTator, text mining | PubMed |
| Co-targeting BET, CBP, and p300 inhibits neuroendocrine signalling in androgen receptor-null prostate cancer. | J Pathol | 2024 | 38578195 | PubTator, text mining | PubMed |
| Distinct Regulation of ASCL1 by the Cell Cycle and Chemotherapy in Small Cell Lung Cancer. | Mol Cancer Res | 2024 | 38512021 | PubTator, text mining | PubMed |
| Comprehensive analysis of transcription factor-based molecular subtypes and their correlation to clinical outcomes in small-cell lung cancer. | EBioMedicine | 2024 | 38492534 | PubTator, text mining | PubMed |
Prognostic significance of immunohistochemical classification utilizing biopsy specimens in patients with extensive-disease small-cell lung cancer treated with first-line chemotherapy and immune checkpoint inhibitors. | J Cancer Res Clin Oncol | 2024 | 38483588 | PubTator, text mining | PubMed |
| Transcription Factors in Brain Regeneration: A Potential Novel Therapeutic Target. | Curr Drug Targets | 2024 | 38444255 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/429/papers?page=18